Free shipping on all orders over $ 500

PSN-375963

Cat. No. M3773
PSN-375963 Structure
Size Price Availability
10mg USD 160  USD160 Out of stock
50mg USD 640  USD640 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PSN-375963 is a selective ligand for the suggested novel cannabinoid receptor GPR119. Initial studies showed that PSN375963 has similar potency and partial efficacy compared to OEA. Further studies revealed that although OEA and PSN375963 are GPR119 agonists, they have divergent effects on insulin secretion, calcium signaling, and cAMP production. Furthermore, we have used the recombinant receptor to discover novel selective small-molecule GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body weight gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats. PSN375963 may be useful as a therapeutic agent for the treatment of obesity.

Chemical Information
Molecular Weight 285.38
Formula C17H23N3O
CAS Number 388575-52-8
Solubility (25°C) DMSO >10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Moran BM, et al. Biol Chem. Activation of GPR119 by fatty acid agonists augments insulin release from clonal β-cells and isolated pancreatic islets and improves glucose tolerance in mice.

[2] Ning Y, et al. Br J Pharmacol. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.

[3] Overton HA, et al. Cell Metab. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents.

Related GPR/FFAR Products
[Ala17]-MCH

[Ala17]-MCH, a MCH analogue, is a selective ligand for MCHR1 (Ki=0.16 nM) over MCHR2 (Ki=34 nM).

BigLEN(rat)

BigLEN(rat) is a potent GPR171 agonist with an EC50 of 1.6 nM.

BigLEN(mouse)

BigLEN(mouse) is a potent and selective agonist of orphan G protein-coupled receptor 171 (GPR171), with a Kd of ∼0.5 nM.

Neuropeptide EI, rat

Neuropeptide EI, rat displays functional melanin concentrating hormone (MCH)-antagonist and melanocyte-stimulating hormone (MSH) agonist activity in different behavioral paradigms.

(Phe13, Tyr19)-MCH (human, mouse, rat)

(Phe13,Tyr19)-MCH (human, mouse, rat) is a potent SLC-1 and S643b receptor ligand.

  Catalog
Abmole Inhibitor Catalog




Keywords: PSN-375963 supplier, GPR/FFAR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.